Lurasidone patent
WebMay 1, 2024 · Lurasidone hydrochloride is an atypical antipsychotic drug. It is used for treating schizophrenia and bipolar depression and is available as a tablet formulation for once daily, administration. WebDec 13, 2024 · PCT Patent Application serial number PCT/US2014/022054 claims priority to U.S. Provisional Patent Application Ser. No. 61/937,021, filed on Feb. 7, 2014. BACKGROUND. ... Lurasidone tablets may be provided in dosages ranging from ten milligrams to sixty milligrams. Sublingual delivery of lurasidone is associated with …
Lurasidone patent
Did you know?
WebMay 15, 2014 · The present invention relates to pharmaceutical compositions of lurasidone or salts thereof. In particular, the invention relates to pharmaceutical compositions of …
WebWe have determined your Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, to be bioequivalent and therapeutically equivalent to the reference listed … WebLurasidone [(3aR,4S,7R,7aS)-2-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl]hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride; SM-13496] is an azapirone derivative and a novel antipsychotic candidate.
WebOct 28, 2010 · Patent 9,827,242 Issued: November 28, 2024 Assignee (s): SUMITOMO DAINIPPON PHARMA CO., LTD. The invention relates to a medicament or a method for … WebLurasidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and children 13 years of age and older. It is also used to treat depression in adults and children 10 years of age and older with bipolar disorder (manic ...
WebJul 18, 2016 · Lurasidone – it having been developed and launched by Sumitomo Dainippon Pharma. Lurasidone was launched for schizophrenia in the US by Sumitomo’s US subsidiary Sunovion Pharmaceuticals. WO 2016110798, Piramal Enterprises Ltd, New Patent, Lurasidone. An improved process for the preparation of lurasidone and its …
WebNov 28, 2024 · 28-11-2024 Print Sumitomo Dainippon Pharma (TYO: 4506) made massive gains in the stock market on Tuesday. The Japanese drugmaker closed up by 18% after announcing the settlement of disputes with generics companies seeking to market copies of its depression drug Latuda (lurasidone). str sell through rateWebJan 28, 2024 · Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application … str service tradeWebLurasidone This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. Brand Names: US Latuda Brand Names: Canada JAMP-Lurasidone; Latuda; PMS-Lurasidone; SANDOZ Lurasidone; TARO-Lurasidone Warning str serviceWebJan 4, 2024 · Brand Name: Latuda • Generic Name: Lurasidone • Patent Expiration Date: January 2024 • Used to treat schizophrenia or bipolar disorder, also known as manic-depression. Brand Name: Restasis • Generic Name: Cyclosporine ophthalmic emulsion • Patent Expiration Date: 2024 str screeningWebApr 12, 2024 · Bipolar disorders (BDs) are recurrent and sometimes chronic disorders of mood that affect around 2% of the world’s population and encompass a spectrum between severe elevated and excitable mood states (mania) to the dysphoria, low energy, and despondency of depressive episodes. The illness commonly starts in young adults and is … str shock force iiWebLurasidone is a medication that works in the brain to treat schizophrenia. It is also known as a second generation antipsychotic (SGA) or atypical antipsychotic. Lurasidone … str shift bWebLurasidone C28H36N4O2S CID 213046 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, … str short tandem repeats definition